Specialised in in-hospital and out-patient market access projects for (orphan) medicinal products, vaccines, pharmacy preparations, cell therapies and medical devices.
In performance of (complex) market access cases (>225 cases)
In market access criteria ‘therapeutic value and cost-effectiveness' (evaluation publications/reports of >450 cases)
Building bridges to market access
Healthcare Consultancy provides strategic advice on medical, pharmaceutical and health economic issues and implements this advice. Need for support by experts, professional societies and other related stakeholders is facilitated by Healthcare Consultancy on a national and international level through its infrastrucutre and network.
Market Access Consultancy on a national level
For the Netherlands, Belgium, Germany, Austria and Switzerland.
- on pricing
- with respect to medical/pharmaceutical and cost-effectiveness aspects in a feasibility analysis format
- dossier writing/consulting or editing (medical/pharmaceutical, budget impact,
- health economic evaluation and modeling
- coordination and execution of market access procedures
Managing the current
The success of market access lies in an early recognition of clinical, economic and legal hurdles. Daily practice teaches that the European strategy, reflected in a core value dossier, fails on subsets. The 'current' in a market access flow has been underestimated. For European headquarters Healthcare Coonsultancy provides a market access scan.
Market Access Consultancy on an European level
Strategic Europe Scan on:
- clinical hurdles
- health economic hurdles
- legal hurdles
- by senior consultants
- with > 20 year of experience
- with extensive network